Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
NR5A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Disorders of Sex Development Panel Invitae United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics United States | 156 | 73 |
|
PreventionGenetics United States | 128 | 85 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics United States | 223 | 238 |
|
PreventionGenetics United States | 128 | 139 |
|
NR5A1-Related Disorders via the NR5A1 Gene PreventionGenetics United States | 3 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
Spermatogenic failure 8 (SPGF8, sequence analysis of NR5A1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Genologica Medica Spain | 25 | 11 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Spermatogenic failure: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 39 | 38 |
|
Fulgent Genetics United States | 16 | 9 |
|
Fulgent Genetics United States | 79 | 45 |
|
Fulgent Genetics United States | 92 | 56 |
|
Fulgent Genetics United States | 76 | 41 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.